Search results
Stress can be "the triggering factor" for skin problems. Dermatologists share their advice.
CBS News· 5 days agoThere are many ways mental health can impact our physical health — but did you know stress can even...
StockNews.com Initiates Coverage on Can-Fite BioPharma (NYSE:CANF)
ETF DAILY NEWS· 10 hours agoStock analysts at StockNews.com assumed coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Free Report) in a research report issued on Friday. The brokerage set a “hold” rating on the ...
UCB Announces Publication in The Lancet of Phase 3 BIMZELX® (bimekizumab-bkzx) Trials in...
KTLA-TV Los Angeles· 3 days agoIn these studies, bimekizumab consistently demonstrated sustained improvements...
Study Identifies Several Onychomycosis Risk Factors
Medscape· 6 days agoTinea pedis, chronic kidney disease, peripheral vascular disease, and type 2 diabetes were associated with an increased risk for onychomycosis in...
TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...
FOX 23 News Albany· 6 days agoWASHINGTON, May 20, 2024 /PRNewswire/ -- Johnson & Johnson today announced the first data from the Phase 3 QUASAR Maintenance Study (Abstract #759) that showed 50.0 percent (p<0.001) of patients ...
Irritable Bowel Disease cases surging in children & adults, experts studying environmental triggers
CBS News· 6 days agoThis World IBD Day, cases of the incurable diseases have surged across the US, and doctors in...
Do LED Skin-Care Devices Even Work?
New York Magazine· 5 days agoLight therapy via at-home LED (light-emitting diodes) devices is trending in skin care right now, but it’s not just a fad. According to Dr. Jared Jagdeo,...
Is TikTok’s #sunbedaddiction the most dangerous trend on social media today?
Harpers BAZAAR· 3 days agoTikTok beauty trends can span the good (heatless styling), the bad (sunscreen contouring) and the...
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?
The Motley Fool via AOL· 6 days agoLuckily, sales of Rinvoq, an arthritis tablet, and Skyrizi, a psoriasis injection, offset the loss. Skyrizi sales soared 47.6% to $2.0 billion and Rinvoq sales jumped 59.3% ...
AbbVie (NYSE:ABBV) vs. Cosmo Pharmaceuticals (OTC:CMOPF) Head to Head Review
ETF DAILY NEWS· 1 day agoAbbVie (NYSE:ABBV – Get Free Report) and Cosmo Pharmaceuticals (OTC:CMOPF – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses ...